Fig. 1From: Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective studyA and B show mesenteric metastases and R0/1 CRS. C and D show metastatic GIST with wide dissemination. Only R2 resection could be performed for these patientsBack to article page